Longaeva Partners’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$38.5M Buy
+2,358,636
New +$44.3M 0.8% 21

Other funds holding TNDM

Longaeva Partners's TNDM Position: Q3 2026 in Review

Longaeva Partners opened a new position in Tandem Diabetes Care (TNDM) in Q3 2026: 2,358,636 shares worth $38.5M. The stake represents 0.8% of the portfolio and ranks #21 among its holdings.

255 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Longaeva Partners held 2,358,636 shares of Tandem Diabetes Care worth $38.5M as of Q3 2026.
  • Tandem Diabetes Care was a new Longaeva Partners position in Q3 2026.
  • Tandem Diabetes Care made up 0.8% of Longaeva Partners's portfolio in Q3 2026, its #21 holding.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.